BioCentury

8:00 AM GMT, Jan 10, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulatory

Omapro omacetaxine mepesuccinate regulatory update

ChemGenex withdrew an MAA for omacetaxine for Gleevec-resistant chronic myelogenous leukemia (CML) in

Read the full 134 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.